Emany Sravan Kumar
SEC Form 4 insider trading activity
Emany Sravan Kumar has filed 4 SEC Form 4 filings (4 transaction rows) across 3 companies, including ASRT, BEAM, KYTX, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: May 6, 2026.
On the most recent filing, Emany Sravan Kumar is listed as Chief Financial Officer at Beam Therapeutics Inc. Inside the rolling window, Emany Sravan Kumar reported no open-market purchases and 1 open-market sale totaling $171K in BEAM.
Companies traded
Other insiders at ASRT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$171K
reported sales (SEC code S)
Companies
3
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Emany Sravan Kumar made?
Emany Sravan Kumar has filed 4 SEC Form 4 filings (4 transaction rows) across 3 companies, including ASRT, BEAM, KYTX since 2026.
Which companies does Emany Sravan Kumar trade?
Emany Sravan Kumar has filed SEC Form 4 disclosures for 3 companies, including ASRT, BEAM, KYTX.
When was Emany Sravan Kumar's most recent SEC Form 4 filing?
Emany Sravan Kumar's most recent SEC Form 4 filing on Tracefour is dated May 6, 2026.
What is Emany Sravan Kumar's total buy and sell value in the current window?
Inside the rolling retention window, Emany Sravan Kumar bought $0 and sold $171K based on SEC Form 4 filings.
What was Emany Sravan Kumar's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 6,294 BEAM shares on 2025-12-31, worth $171K, per SEC Form 4 filings.